Phoenix, AZ, United States of America

Landon J Inge

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Landon J Inge: Innovator in Cancer Treatment

Introduction

Landon J Inge is a notable inventor based in Phoenix, AZ, who has made significant contributions to the field of cancer treatment. With a total of 4 patents to his name, Inge's work focuses on innovative methods for treating cancer, particularly through the use of checkpoint inhibitors.

Latest Patents

Inge's latest patents include systems and methods for treating cancer. These embodiments provide a method of treating cancer by contacting cancer cells with a therapeutically effective amount of a G2/M checkpoint inhibitor. The methods also involve receiving a sample of cancer cells from a subject, determining if the sample is LKB1 deficient, and then treating the cancer cells accordingly. Additionally, his inventions include methods for prognosing the severity of cancer based on the presence of LKB1 in the cancer cells.

Career Highlights

Throughout his career, Inge has worked with reputable organizations such as Dignity Health and the Translational Genomics Research Institute. His experience in these institutions has allowed him to collaborate with other professionals in the field and further his research in cancer treatment.

Collaborations

Inge has collaborated with Timothy G Whitsett, Jr., enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Landon J Inge is a dedicated inventor whose innovative approaches to cancer treatment are paving the way for advancements in medical science. His contributions are vital in the ongoing fight against cancer, and his work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…